ShiraTronics, Inc. receives FDA Breakthrough Device Designation for Chronic Migraine Neurostimulation

ShiraTronics has announced that it has been granted a breakthrough device designation by the Center of Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) for its neurostimulation therapy targeting chronic migraine sufferers…